US 2016/0106722 A1 · HUMAN THERAPEUTIC AGENTS

Abstract

Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.

Claims17

Dependent claims

A therapeutic composition comprising the combination of at least one isovanillin component comprising isovanillin and at least one harmine component comprising harmine, wherein the components of the composition are different, said isovanillin being synthetically derived or derived from naturally occurring product(s) containing said isovanillin which have been treated so that the isovanillin is present at a level of at least about 25% by weight in the treated naturally occurring product(s), and said harmine being synthetically derived or derived from naturally occurring product(s) containing said harmine which have been treated so that the harmine is present at a level of at least about 25% by weight in the treated naturally occurring product(s).

Dependencies are inferred from the claim text.

Facts

Application

14/721,018Filed 26 May 2015

Priority

21 Oct 2014

Published

21 Apr 2016

Term ends

Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 31/4375
Ortho- or peri-condensed with heterocyclic ring systems: the heterocyclic ring system containing a six-membered ring having nitrogen as a ring…
A61K 31/11
Medicinal preparations containing organic active ingredients: aldehydes
A61K 31/12
Medicinal preparations containing organic active ingredients: ketones
A61K 31/192
Carboxylic acids, e.g. valproic acid: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid

Abstract

Claims17

Dependent claims

Dependencies are inferred from the claim text.

Human therapeutic agents

Life of this patent

Abstract

Claims17

Human therapeutic agents

Life of this patent

Abstract

Claims17